Neuro-oncology involves the diagnosis, treatment, and investigation of brain and central nervous system cancers. The session "Neuro-Oncology" presents the most recent developments in the understanding of tumor biology, enhancing patient care, and designing novel treatments for these intricate and frequently challenging neoplasms.
Common neuro-oncologic disorders are gliomas, meningiomas, medulloblastomas, and metastatic brain tumors. Proper diagnosis is dependent on sophisticated imaging modalities, molecular analysis, and occasionally surgical biopsy to identify the tumor type and direct treatment planning. Prompt detection and accurate characterization are essential for maximizing patient outcomes.
Treatment options involve surgery, radiation, chemotherapy, targeted therapy, and newer immunotherapies. Multidisciplinary treatment is necessary, with the involvement of neurosurgeons, oncologists, radiologists, and supportive care teams to address both the tumor and related neurological symptoms. The session also touches on new research, such as gene therapy, personalized medicine, and clinical trials designed to enhance survival and quality of life for patients.
Participating delegates will learn about the newest diagnostic techniques, treatment methods, and cutting-edge research that will define the future of neuro-oncology. This session stresses the significance of individualized strategies, early treatment, and multidisciplinary care in the best management of central nervous system and brain cancers.
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
